Related Experiment Video
Updated: Mar 11, 2026
A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome
Published on: May 22, 2019
Generation and analysis of the Rett syndrome-associated MeCP2- null rat model
Abstract:
MeCP2 mutations are associated with the Rett syndrome (RTT). Currently, there is an urgent need for new animal models for RTT as the existing MeCP2 knockout mouse models fail to fully mimic the pathogenesis and symptoms of RTT patients. In order to investigate the role of MeCP2 in brain development and RTT pathogenesis, we aimed to set up the MeCP2-null rat model using the CRISPR/Cas9 technology. Firstly we constructed the MeCP2 targeting vector and then microinjected Cas9 mRNA and sgRNA mixtures into fertilized ova of SD rats. The sgRNA was designed to target the exon 2 of MeCP2. Next, knockout rats were confirmed using DNA sequencing and Western blotting. Lastly, phenotypes including growth and behaviors of MeCP2 knockout rats were analyzed. The results indicated that the MeCP2 knockout rats showed body weight loss, anxiety tendency and cognitive deficits. The MeCP2-null rat model established in this study recapitulates the major symptoms of RTT patients and provides an alternative tool for future studies of MeCP2 functions.
Insights
Researchers developed a new MeCP2-null rat model using CRISPR/Cas9 technology. This model effectively mimics Rett syndrome (RTT) symptoms, offering a valuable tool for studying MeCP2 functions and RTT pathogenesis.
Area of Science:
- Neuroscience
- Genetics
- Developmental Biology
Background:
- MeCP2 mutations cause Rett syndrome (RTT).
- Existing mouse models do not fully replicate RTT pathogenesis and symptoms.
- There is a critical need for improved RTT animal models.
Purpose of the Study:
- To establish a MeCP2-null rat model using CRISPR/Cas9 technology.
- To investigate the role of MeCP2 in brain development and RTT.
- To create a more accurate model for RTT research.
Main Methods:
- CRISPR/Cas9 technology was employed to create MeCP2 knockout rats.
- sgRNA targeted exon 2 of the MeCP2 gene.
- Confirmation of knockout rats via DNA sequencing and Western blotting.
- Phenotypic analysis included growth and behavioral assessments.
Main Results:
- MeCP2 knockout rats exhibited significant body weight loss.
- The rats displayed increased anxiety tendencies.
- Cognitive deficits were observed in the MeCP2-null rats.
- The established rat model recapitulates key RTT symptoms.
Conclusions:
- The MeCP2-null rat model is a viable alternative for RTT research.
- This model provides new insights into MeCP2 functions in brain development.
- The model aids in understanding RTT pathogenesis and developing therapies.
